Paper33929324
CD8+ T cell self-tolerance permits responsiveness but limits tissue damage.
Truckenbrod EN and 10 others. Elife, 2021. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. CD8+ T cell self-tolerance permits responsiveness but limits tissue damage. Papers, record 33929324. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33929324
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CD8-Positive T-Lymphocytes | Major topic |
| Self Tolerance | Major topic |
| Animals | |
| Cell Differentiation | |
| Female | |
| Interleukin-2 Receptor alpha Subunit | |
| Intramolecular Oxidoreductases | |
| Male | |
| Mice | |
| Mice, Inbred C57BL | |
| Vitiligo |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| T32 OD010993 | NIH HHS | United States | T32OD010993 | PubMed and NIH | NIH RePORTER |
| T32 CA009138 | NCI NIH HHS | United States | T32CA009138 | PubMed and NIH | NIH RePORTER |
| P01 AI035296 | NIAID NIH HHS | United States | P01AI035296 | PubMed and NIH | NIH RePORTER |
| R01 AI140631 | NIAID NIH HHS | United States | R01AI140631 | PubMed and NIH | NIH RePORTER |
References70
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24907378 | IL-2: the first effective immunotherapy for human cancer. | J Immunol | 2014 | https://conductscience.org/library/papers/24907378 | PubMed |
| 2 | 9858516 | CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. | J Exp Med | 1998 | https://conductscience.org/library/papers/9858516 | PubMed |
| 3 | 16879996 | T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity. | Immunity | 2006 | https://conductscience.org/library/papers/16879996 | PubMed |
| 4 | 19903852 | Optimized peptide vaccines eliciting extensive CD8 T-cell responses with therapeutic antitumor effects. | Cancer Res | 2009 | https://conductscience.org/library/papers/19903852 | PubMed |
| 5 | 25992863 | Clonal Deletion Prunes but Does Not Eliminate Self-Specific αβ CD8(+) T Lymphocytes. | Immunity | 2015 | https://conductscience.org/library/papers/25992863 | PubMed |
| 6 | 29608179 | Integrating single-cell transcriptomic data across different conditions, technologies, and species. | Nat Biotechnol | 2018 | https://conductscience.org/library/papers/29608179 | PubMed |
| 7 | 1901764 | Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. | Cell | 1991 | https://conductscience.org/library/papers/1901764 | PubMed |
| 8 | 18424696 | Cutting edge: Enhanced IL-2 signaling can convert self-specific T cell response from tolerance to autoimmunity. | J Immunol | 2008 | https://conductscience.org/library/papers/18424696 | PubMed |
| 9 | 17382557 | Molecular basis for checkpoints in the CD8 T cell response: tolerance versus activation. | Semin Immunol | 2007 | https://conductscience.org/library/papers/17382557 | PubMed |
| 10 | 28648661 | De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation. | Cell | 2017 | https://conductscience.org/library/papers/28648661 | PubMed |
| 11 | 21220453 | High prevalence of low affinity peptide-MHC II tetramer-negative effectors during polyclonal CD4+ T cell responses. | J Exp Med | 2011 | https://conductscience.org/library/papers/21220453 | PubMed |
| 12 | 17086201 | Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling. | Nature | 2006 | https://conductscience.org/library/papers/17086201 | PubMed |
| 13 | 11163198 | Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion. | Immunity | 2000 | https://conductscience.org/library/papers/11163198 | PubMed |
| 14 | 16200080 | Central tolerance: learning self-control in the thymus. | Nat Rev Immunol | 2005 | https://conductscience.org/library/papers/16200080 | PubMed |
| 15 | 22987800 | Autoreactive T cells bypass negative selection and respond to self-antigen stimulation during infection. | J Exp Med | 2012 | https://conductscience.org/library/papers/22987800 | PubMed |
| 16 | 29925986 | Thymic tolerance as a key brake on autoimmunity. | Nat Immunol | 2018 | https://conductscience.org/library/papers/29925986 | PubMed |
| 17 | 15780985 | Peripheral tolerance of CD8 T lymphocytes. | Immunity | 2005 | https://conductscience.org/library/papers/15780985 | PubMed |
| 18 | 19182777 | Complete but curtailed T-cell response to very low-affinity antigen. | Nature | 2009 | https://conductscience.org/library/papers/19182777 | PubMed |
| 19 | 18759926 | Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. | Immunol Rev | 2008 | https://conductscience.org/library/papers/18759926 | PubMed |
| 20 | 16778891 | Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells. | Nature | 2006 | https://conductscience.org/library/papers/16778891 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42086715 | CD8+ T cells in atherosclerosis and coronary artery disease. | Nat Rev Cardiol | 2026 | https://conductscience.org/library/papers/42086715 | PubMed |
| 41491403 | Targeting autocrine retinoic acid signaling by ALDH1A2 inhibition enhances antitumor dendritic cell vaccine efficacy. | Nat Immunol | 2026 | https://conductscience.org/library/papers/41491403 | PubMed |
| 41482575 | The immunology of vitiligo. | Nat Rev Immunol | 2026 | https://conductscience.org/library/papers/41482575 | PubMed |
| 39801736 | T Cell Resistance: On the Mechanisms of T Cell Non-activation. | Immune Netw | 2024 | https://conductscience.org/library/papers/39801736 | PubMed |
| 38776918 | The CD8+ T cell tolerance checkpoint triggers a distinct differentiation state defined by protein translation defects. | Immunity | 2024 | https://conductscience.org/library/papers/38776918 | PubMed |
| 38571942 | Activated B-Cells enhance epitope spreading to support successful cancer immunotherapy. | Front Immunol | 2024 | https://conductscience.org/library/papers/38571942 | PubMed |
| 36100367 | Strong Basal/Tonic TCR Signals Are Associated with Negative Regulation of Naive CD4+ T Cells. | Immunohorizons | 2022 | https://conductscience.org/library/papers/36100367 | PubMed |
| 34653787 | Functional heterogeneity and adaptation of naive T cells in response to tonic TCR signals. | Curr Opin Immunol | 2021 | https://conductscience.org/library/papers/34653787 | PubMed |
| 33929324 | CD8+ T cell self-tolerance permits responsiveness but limits tissue damage. | Elife | 2021 | https://conductscience.org/library/papers/33929324 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| FOXP3 | 50943 | PubTator's text mining | https://conductscience.org/library/genes/50943 | NCBI Gene |
| TRBV20OR9-2 | 6962 | PubTator's text mining | https://conductscience.org/library/genes/6962 | NCBI Gene |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GEO | GSE171221 |
Source GEO
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33929324
GET https://conductscience.org/api/papers/v1/33929324/references?page=2